January 2015


Biofortuna Ltd closes a £1.5m funding round

Biofortuna Ltd, the UK based molecular diagnostics company specialising in its proprietary freeze-dried diagnostics and contract services, announces raising £1.5m in its latest funding round. The £1.5m funding was supported by all the company’s current investors; Foresight VCTs, Catapult Ventures, Enterprise Ventures, MSIF, private investors and management. The new funding is for Biofortuna to develop a portfolio of new molecular

Read more